Recent Advances in CMV Management in HSCT Recipients in the Era of Letermovir

TRANSMITTED LIVE ON
Friday, October 2nd, 2026
17:30 -19:00 CEST
10 days replay - subject to country regulations

Register Now

SASS: Recent Advances in CMV Management in HSCT Recipients in the Era of Letermovir

October, 2nd, 2026 17:30 -19:00 CEST Chair: Prof. Per Ljungman (Sweden)
17:30-17:35
Welcome, introduction and opening remarks
Prof. Per Ljungman (Sweden)
17:35-17:50
The burden of CMV in HSCT, major milestones and remaining challenges in CMV management
Prof. Per Ljungman (Sweden)
17:50-18:10
Effectiveness of letermovir extended use in adult HSCT recipients: phase-3 and emerging real-world evidence
Prof. Genovefa Papanicolaou (USA)
18:10-18:30
Advancing CMV management in Pediatric HSCT
Prof. Krzysztof Kałwak (Poland)
18:30-18:50
Panel discussion and Q&A session
All Speakers & Chair
18:50-18:55
Closing Remarks
Prof. Per Ljungman (Sweden)